To date, a number of disease-associated mutations, specifically in ALS and frontotemporal dementia (FTD), have been identified that perturb TBK1 binding with optineurin, resulting in dysfunction of trafficking pathways such as autophagy (43). This evidence concerns the gene TBK1 and amyotrophic lateral sclerosis.